Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11427563 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Patent 11427563 was granted and assigned to Aerie Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11891376 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andriy Kornilov0
Cynthia L. Lichorowic0
Jill M. Sturdivant0
Mitchell A. deLong0
Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11707460 Ophthalmic compositions
0
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Aerie Pharmaceuticals
Aerie Pharmaceuticals
0
Current Assignee
Aerie Pharmaceuticals
Aerie Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114275630
Date of Patent
August 30, 2022
0
Patent Application Number
165708490
Date Filed
September 13, 2019
0
Patent Citations
‌
US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10174017 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10654844 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10858339 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 10882840 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10899714 6-aminoisoquinoline compounds
0
Patent Primary Examiner
‌
D Margaret M Seaman
0
CPC Code
‌
C07D 413/12
0
‌
C07D 405/12
0
‌
C07D 401/14
0
‌
C07D 401/12
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 31 Aug, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 31 Aug, 2022
Edits made to:
Infobox (+19 properties)
Article (+436 characters)
‌

 US Patent 11427563 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Article

Provided herein are amino isoquinolinyl amide and sulfonamide compounds that affect the function of kinases and other proteins in a cell and that are useful as therapeutic agents. In particular, these compounds are useful in the treatment of eye diseases such as glaucoma and retinal diseases, as anti-inflammatory agents, for the treatment of cardiovascular diseases, and for diseases characterized by abnormal growth, such as cancers.

Infobox
Is a
Patent
Patent
Patent Applicant
Aerie Pharmaceuticals
Aerie Pharmaceuticals
Current Assignee
Aerie Pharmaceuticals
Aerie Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11427563
Date of Patent
August 30, 2022
Patent Application Number
16570849
Date Filed
September 13, 2019
Patent Citations
‌
US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
‌
US Patent 10174017 Dual mechanism inhibitors for the treatment of disease
‌
US Patent 10654844 Dual mechanism inhibitors for the treatment of disease
‌
US Patent 10858339 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
‌
US Patent 10882840 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
‌
US Patent 10899714 6-aminoisoquinoline compounds
Patent Primary Examiner
‌
D Margaret M Seaman
CPC Code
‌
C07D 413/12
‌
C07D 405/12
‌
C07D 401/14
‌
C07D 401/12

Find more entities like US Patent 11427563 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo